Breakwater Capital Group Bristol Myers Squibb CO Transaction History

Breakwater Capital Group

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $152,134 - $170,110	-2,628 Reduced 24.75%	7,992 $410 Million
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $101,362 - $112,547	-1,591 Reduced 13.03%	10,620 $679 Million
Q1 2023 Apr 26, 2023	BUY	$65.71 - $74.53 $59,993 - $68,045	913 Added 8.08%	12,211 $846 Million
Q4 2022 Feb 02, 2023	BUY	$68.48 - $81.09 $773,687 - $916,154	11,298 New	11,298 $813 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Breakwater Capital Group, based on Form 13F filings with the SEC.

Stay updated on Breakwater Capital Group with notifications on news.